b'I n v i v o s c r i b eB o a r d o f D i r e c t o r s Jeffrey Edward Miller, Ph.D. Dr. Miller is a scientist, inventor, and entrepreneur focused on Improving Lives with Precision Diagnostics coupling drug trials and therapeutic treatment regimens with optimized clinically-actionable diagnostic methods in order to select the correct patients and then monitor and track their response throughout the course of their disease. He received his undergraduate degree in Biochemistry from UCLA and a combined Hardwick Simmons, MBA Ph.D. in Biochemistry & Molecular Biology from UCSB. Prior to starting Invivoscribe, Dr. Miller had more than twenty years of combined experience in protein biochemistry, cellular and molecular immunology, cardiac Hardwick Wick Simmons retired as the Chairman and CEO of The Nasdaq Stock Market, Inc. in May ofphysiology, virology, and molecular biology, experience he had developed working in laboratories at the 2003. Prior to Nasdaq, he served as President and CEO of Prudential Securities Inc., a major investmentMedical School, Department of Chemistry, Molecular Biology Institute at UCLA, while earning his Ph.D. at management and securities brokerage firm. Simmons is a former chairman of the Securities IndustryUCSB, and as a postdoctoral scientist at Applied Molecular Evolution. He also spent several years at Quest Association, a former director of the Chicago Board Options Exchange and a former president of the NewDiagnostics Nichols Institute, setting up the molecular oncology laboratory and developing and launching York Bond Club. He is currently a director of Lionsgate Entertainment Corp., president of Stonetex Oil Corp.,PCR-based molecular assays for infectious disease and hematopathology.and a trustee of Woods Hole Oceanographic Institution. He is a graduate of Harvard College and HarvardJeffrey Edward MillerBusiness School and served in the U.S. Marine Corps Reserve from 1960 until 1966.James Isaacs, Jr., JD.James B. Isaacs, Jr. has practiced law since 1983. He currently serves as Licensing and Contracts Counsel Hardwick Simmons at Invivoscribe. Jim attended Stanford University and Yale Law School, then began his career at the Los Angeles law firm of OMelveny & Myers. As a trial lawyer and later in-house counsel with a focus on intellectual property disputes, Jim has successfully defended a myriad of businesses and individuals; in Mitchell Kronenberg, Ph.D. plaintiffs actions he has obtained and collected multi-million dollar judgments in the United States and abroad. As a businessman and co-founder of Invivoscribe, Jim has been active in the legal and commercial Mitchell Kronenberg received a B.A. from Columbia University, a Ph.D. from the California Institute ofaffairs of the company since 1995.Technology, and served on the faculty of the UCLA School of Medicine from 1986-1997. He joined the La Jolla Institute for Immunology in 1997, and has been the President there since 2003. The Institute has grown in accomplishment and reputation under his leadership. Dr. Kronenbergs research interests include natural killer T cells, other innate lymphocytes such as MAIT cells and ILC, regulation of mucosal immunology and the microbiome and pathogenesis of inflammatory bowel disease. He has co-authored more thanJames Isaacs, Jr.350 publications, and is a fellow of the American Association for the Advancement of Science (AAAS), a Distinguished Fellow of the American Association of Immunologists, recipient of an NIH MERIT award and is an Institute for Scientific Information (ISI) Highly Cited Scientist. In 2016, he was named the most admiredGary Clouse, JD.CEO (large nonprofit organization category) by the San Diego Business Journal. He is an advisor to a number of organizations including service as a member of the Board of Scientific Counselors for BasicGary Clouse has practiced as a litigator and business attorney in Southern California for more than three Mitchell Kronenberg Science, National Cancer Institute and he has been involved with Invivoscribe since its founding. decades. He currently serves as Corporate Secretary and Legal Counsel for Special Projects at Invivoscribe. Clouse is a graduate of Indiana State University and Northwestern University School of Law. Following law school, he clerked for the federal Seventh Circuit Court of Appeals in Chicago. He began his legal practice Stephen Wilson, Ph.D. at the law firm OMelveny & Myers in Los Angeles. Clouse is one of the founders of invivoscribe.Dr. Wilson is a biomedical research executive with more than two decades of experience in basic and translational immunology. He received his B.S.A. and Ph.D. from the University of Arizona, and serves as the Executive Vice President and Chief Operating Officer of the La Jolla Institute for Immunology.Gary ClouseImproving the quality of healthcare worldwide.Stephen Wilson Committed to providing high quality, reliable, cutting-edge tools for molecular diagnostic and personalized molecular medicine.6Invivoscribe 2021|7'